NutribandNTRB -0.93%59 Gross Margin % is 45.50% as of Apr. 2026, which is 33% above its 10-year median of 34.10. GuruFocus rates NTRB with a GF Score™ of 59/100 and a GF Value™ of $3.25 (Fairly Valued). The stock has 4 warning signs investors should review. Among 735 Biotechnology companies, Nutriband ranks worse than 77.55% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Nutriband's Gross Profit for the
three
months ended in Apr. 2026 was $0.20 Mil. Nutriband's Revenue for the
three
months ended in Apr. 2026 was $0.43 Mil. Therefore, Nutriband's Gross Margin % for the quarter that ended in Apr. 2026 was 45.50%.
Warning Sign:
Nutriband Inc gross margin has been in long-term decline. The average rate of decline per year is -2.4%.
The historical rank and industry rank for Nutriband's Gross Margin % or its related term are showing as below:
NTRB'
s Gross Margin % Range Over the Past 10 Years
Min: -47.98 Med: 34.1 Max: 41.34
Current: 28.41
During the past 11 years, the highestGross Margin % of Nutriband was 41.34%. The lowest was -47.98%. And the median was 34.10%.
NTRB's Gross Margin % is ranked worse than 77.55% of 735
companies
in the Biotechnology industry
Industry Median: 60.9
vs NTRB: 28.41
Nutriband had a gross margin of 45.50% for the quarter that ended in Apr. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Nutriband was -2.40% per year.
Nutriband (NAS:NTRB) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Nutriband had a gross margin of 45.50% for the quarter that ended in Apr. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Nutriband Gross Margin % Related Terms
Nutriband Gross Margin % Historical Data
* Premium members only.
The historical data trend for Nutriband's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NTRB vs INMB, GRCE, ALGS: Gross Margin % Comparison
For the Biotechnology subindustry, Nutriband's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutriband Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nutriband's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Nutriband's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Nutriband (NTRB) has a Gross Margin % of 45.50% as of Apr. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Nutriband and its competitors. This is 33% above median its historical median of 34.10. According to the industry distribution chart, Nutriband ranks #570 out of 735 companies in the Biotechnology industry, placing it in the top 77.6%.
Is Nutriband's Gross Margin % too high?
Nutriband's current Gross Margin % of 45.50% is 33% above median its 10-year median of 34.10. The Biotechnology industry median Gross Margin % is 60.90. Nutriband's value of 45.50% is 25.3% below this industry median. Based on the distribution chart, Nutriband ranks #570 out of 735 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Nutriband has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nutriband's Gross Margin % compare to INMB and GRCE?
According to the Biotechnology industry distribution chart, Nutriband ranks #570 out of 735 companies for Gross Margin %. This places Nutriband in the lower half of its industry. The industry median Gross Margin % is 60.90. Nutriband's value of 45.50% is 25.3% below this benchmark. While the company's 10-year median is 34.10 vs. the industry median of 60.90, Nutriband has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nutriband's current Gross Margin % of 45.50% is 25.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Nutriband and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutriband's current Gross Margin % is 45.50%, which is 33% above median its own 10-year median of 34.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutriband stock overvalued right now?
Based on GuruFocus' analysis, Nutriband (NTRB) is currently considered Fairly Valued. The stock's GF Value™ is $3.25, compared to a current price of $3.18 — trading 2.2% below its estimated fair value. The current Gross Margin % is 45.50%, which is 33% above median its 10-year median of 34.10 and 25.3% below the Biotechnology industry median of 60.90. Nutriband's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Nutriband (NTRB), the current Gross Margin % is 45.50% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nutriband (NTRB) Overvalued in 2026?
Based on GuruFocus' analysis, Nutriband stock appears to be undervalued.
The current stock price of $3.18 is trading 2.2% below its estimated GF Value™ of $3.25.
GuruFocus considers Nutriband to be Fairly Valued.
Key valuation signals for NTRB:
Gross Margin %: 45.50% (33% above median its 10-year median of 34.10)
GF Value™: $3.25 vs. price of $3.18 (2.2% below fair value)
Industry Position: 25.3% below the Biotechnology median (#570 of 735)
No single metric tells the full story. See the NTRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
59GF Score
Get the complete analysis for NTRB
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NTRB has been successfully added to your 
